These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37759637)

  • 1. Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion.
    Tomczewski MV; Chan JZ; Al-Majmaie DM; Liu MR; Cocco AD; Stark KD; Strathdee D; Duncan RE
    Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Characterization of Male
    Tomczewski MV; Chan JZ; Campbell ZE; Strathdee D; Duncan RE
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.
    Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S
    Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.
    Suzuki-Hatano S; Saha M; Rizzo SA; Witko RL; Gosiker BJ; Ramanathan M; Soustek MS; Jones MD; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Hum Gene Ther; 2019 Feb; 30(2):139-154. PubMed ID: 30070157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated liver glycogenolysis mediates higher blood glucose during acute exercise in Barth syndrome.
    Schweitzer GG; Ditzenberger GL; Hughey CC; Finck BN; Martino MR; Pacak CA; Byrne BJ; Cade WT
    PLoS One; 2023; 18(8):e0290832. PubMed ID: 37651450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV9-
    Suzuki-Hatano S; Saha M; Soustek MS; Kang PB; Byrne BJ; Cade WT; Pacak CA
    Mol Ther Methods Clin Dev; 2019 Jun; 13():167-179. PubMed ID: 30788385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes.
    Zegallai HM; Abu-El-Rub E; Mejia EM; Sparagna GC; Cole LK; Marshall AJ; Hatch GM
    Cell Tissue Res; 2022 Dec; 390(3):429-439. PubMed ID: 36129532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Mitochondrial Ca
    Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C
    Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome.
    Wang S; Yazawa E; Keating EM; Mazumdar N; Hauschild A; Ma Q; Wu H; Xu Y; Shi X; Strathdee D; Gerszten RE; Schlame M; Pu WT
    Hum Mol Genet; 2023 Jun; 32(12):2055-2067. PubMed ID: 36917259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression.
    Jagirdar G; Elsner M; Scharf C; Simm S; Borucki K; Peter D; Lalk M; Methling K; Linnebacher M; Krohn M; Wolke C; Lendeckel U
    Front Genet; 2022; 13():931017. PubMed ID: 35957687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Fatica EM; DeLeonibus GA; House A; Kodger JV; Pearce RW; Shah RR; Levi L; Sandlers Y
    Metabolites; 2019 Dec; 9(12):. PubMed ID: 31861102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.